ADRC Affiliated Researchers

Jenna Merenstein, Ph.D.

Duke University
Biomarkers
Cognition
Neuroimaging
Research summary: My research uses multiple MRI modalities (diffusion, fMRI) to assess the effect of brain aging on various cognitive abilities (memory, learning, attention) in adults across the lifespan. An overarching goal of my work is to differentiate the neural signatures of healthy brain aging from Alzheimer’s disease.

Katie Meyer, ScD

UNC-Chapel Hill
Nutritional and cardiovascular disease epidemiologist.

Michelle Meyer, Ph.D., MPH

UNC-Chapel Hill
Cardiovascular Epidemiology, Women’s Health

Sandra Mooney, Ph.D.

UNC-Chapel Hill
Uses animal models to test nutritional interventions that may ameliorate alcohol-induced deficits as well as examining other factors, such as genes and nutrition, that confer vulnerability or resistance.

Rajendra Morey, M.D.

Duke University
Research in my lab is focused on brain changes associated with posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), and other neuropsychiatric disorders. We apply several advanced methods for understanding brain function including functional MRI, structural MRI, diffusion tensor imaging, and genetic effects.

Sheryl Moy, Ph.D.

UNC-Chapel Hill
Genetics
Genetic and environmental factors in susceptibility to neurodevelopmental disorders, and preclinical efficacy testing with novel therapeutic agents, using mouse models for psychiatric and neurological conditions.

David Murdoch, M.D.

Duke University
My research focuses on T cell immunology utilizing a variety of platforms including polychromatic flow cytometry, cytokine multiplexing, and novel single cell assays.

Marc Niethammer, Ph.D.

UNC-Chapel Hill
Medical image analysis; shape analysis, image segmentation, deformable registration, image-based estimation methods.

Joshua Niznik, PharmD, Ph.D.

UNC-Chapel Hill
Genetics
Clinical pharmacy; pharmacoepidemiology; Geriatrics; health services research; Medicare administrative data; polypharmacy; deprescribing chronic medications that may no longer have value for patients

Kari North, Ph.D.

UNC-Chapel Hill
Genetics
Cardiovascular disease and associated risk factors.

Bernadette O’Donovan, Ph.D., MSc

Duke University
Alzheimer’s Disease
Neurodegeneration
Member of Chiba-Falek’s lab – electrophysiology, microscopy, behavioral techniques, genetic and pharmacological models, and data analysis

Richard O’Brien, MD, PhD

Core Leader

Duke University
Clinical Trials
Cognition
Neurodegeneration

Priya Palta, Ph.D., MHS

Associate Professor of Neurology

UNC-Chapel Hill
Her current work focuses on the role of modifiable risk factors, such as physical activity, on cognition, physical function and quality of life metrics.

Kelly Parsons, Ph.D.

UNC-Chapel Hill
Director of technology commercialization at UNC Innovate Carolina.

Juliessa Pavon, M.D.

Duke University
Aging; data science; hospital care; older people; medical informatics; digital health; physical functions and mobility; polypharmacy.

Chelsea Perfect, M.D., MPH

Duke University
My research focuses on models of care for adults living with cognitive impairment and/or dementia.

Darina Petrovsky, PhD, RN

Assistant Professor of Nursing, Division of Women, Children, and Families

Duke University
Alzheimer’s Disease
Care Givers & Community Support
Clinical Trials
Dementia Care
I am funded on a K23 from the NIA and the Alzheimer’s Association to examine the impact of music-based interventions on sleep in persons living with dementia and their caregivers.

Carl Pieper, DrPH

Duke University
Analytic Interests: Issues in the design of medical experiments and Issues in the analysis of repeated measures designs & longitudinal data.

Laura Porter, Ph.D.

Duke University
My research focuses on developing and evaluating behavioral interventions to help patients and their family members cope with the symptoms and psychological demands associated with chronic and life-limiting illness.